Suchergebnisse - "O3J8G9O825"

PubPharm (510)

1

A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir

enthalten in: Clinical pharmacokinetics | 2024

von Gerhart, J. | Cox, D. | Singh, R. | +6

2

Association of nirmatrelvir for acute SARS-CoV-2 infection with subsequent Long COVID symptoms in an observational cohort study

enthalten in: Journal of medical virology | 2024

von Durstenfeld, M. | Peluso, M. | Lin, F. | +10

3

Prevalence and risk factors of metabolic syndrome in Ethiopia : describing an emerging outbreak in HIV clinics of the sub-Saharan Africa - a cross-sectional study

enthalten in: BMJ open | 2023

von Abdela, A. | Yifter, H. | Reja, A. | +3

4

Adverse outcomes in SARS-CoV-2-infected pregnant mice are gestational age-dependent and resolve with antiviral treatment

enthalten in: The Journal of clinical investigation | 2023

von Creisher, P. | Perry, J. | Zhong, W. | +10

UpdateOf: bioRxiv. 2023 Jun 25;:. - PMID 36993658

5

First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children : A Substudy of the CHAPAS-4 Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Waalewijn, H. | Szubert, A. | Wasmann, R. | +18

6

Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections

enthalten in: JAMA network open | 2023

von Lin, D. | Abi Fadel, F. | Huang, S. | +5

7

Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models

enthalten in: Nature communications | 2023

von Cox, R. | Lieber, C. | Wolf, J. | +11

8

Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients

enthalten in: Pharmacotherapy | 2023

von Salerno, S. | Capparelli, E. | McIlleron, H. | +5

9

The Coronavirus Disease 2019 Rebound Study : A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences in Participants Treated With Nirmatrelvir Plus Ritonavir Versus Untreated Controls

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Pandit, J. | Radin, J. | Chiang, D. | +5

10

Your Outpatient has Coronavirus Disease 2019 : What Are the Treatment Options in the Current Severe Acute Respiratory Syndrome Coronavirus 2 Variant Climate?

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Werbel, W. | Weld, E. | Advani, S. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[51]